Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. by Massi, Daniela et al.
EXTRAORDINARY CASE REPORT
Atypical CD30+ Cutaneous Lymphoid Proliferation in a
Patient With Tuberculosis Infection
Daniela Massi,* Michele Trotta,† Alessandro Franchi,* Nicola Pimpinelli,‡ and Marco Santucci*
Abstract: We describe the case of a 65-year-old woman affected by
a diffuse lymphadenopathy consistent with tuberculous infection who
developed a papular eruption on the head and neck region. Histopath-
ologic examination of one papule showed an atypical CD30+ lym-
phoid infiltrate, which initially was cause of concern for the patholo-
gists but was eventually regarded as reactive in nature. The case re-
ported herein enlarges the spectrum of inflammatory infiltrates in
which atypical CD30+ cells may be found. Since the reactive atypical
CD30+ cells are morphologically similar to those cells observed in
CD30+ lymphoproliferative disorders, including lymphomatoid
papulosis, complete clinical history and laboratory findings are nec-
essary to make the final and correct diagnosis. Although the pathoge-
netic relevance of the presence of CD30+ cells within the cutaneous
infiltrate of patients with systemic tuberculosis remains to be deter-
mined, our findings support the hypothesis that the cytokine profile
associated with tuberculosis may not be strictly TH1-like, and that a
TH1-like to TH2-like switch may also occur.
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Tuberculosis (TBC) may rarely involve the skin, featuring awide spectrum of clinicopathologic entities that are gener-
ally classified according to time of infection (primary versus
secondary), presumed route of infection, and clinical appear-
ance. In particular, lupus vulgaris is the most common form of
TBC reinfection, affecting primarily the head and neck region
of young patients. The usual clinical picture is with multiple
erythematous papules forming a plaque, which on diascopy
shows small “apple jelly” nodules. Histopathologically, there
are confluent granulomas surrounded by variables mantles of
lymphocytes; central caseation necrosis and Langhans giant
cells are sometimes present. Tuberculids are a heterogeneous
group of cutaneous lesions that occur in association with TBC
infection in patients with a high degree of immunity and aller-
gic sensitivity to the organism.
We herein describe the case of a 65-year-old woman af-
fected by a diffuse lymphadenopathy consistent with tubercu-
losis who developed a papular eruption on the head and neck
region. Histopathologic examination of one papule showed an
atypical CD30+ lymphoid infiltrate that initially was cause of
concern for the pathologists, but was eventually regarded as
reactive. The true nature and the possible pathogenetic signifi-
cance of the peculiar picture observed are discussed.
CASE REPORT
A 65-year-old woman presented with a diffuse lymph-
adenopathy, involving the cervical and left axillary lymph
nodes, associated with night sweats, weight loss, and weak-
ness. A computed tomography scan demonstrated also the
presence of enlarged mediastinal lymph nodes, whereas chest
radiographs failed to show lung infiltration. The left axillary
lymph node was surgically excised. Histopathologic examina-
tion revealed the presence of multiple epithelioid granulomas
surrounded by mantles of lymphocytes and not associated with
significant caseous necrosis. The histopathologic findings
were considered consistent with a diagnosis of lymph node
TBC. A Ziehl-Neelsen stain was negative. A nested polymer-
ase chain reaction assay for amplification of Mycobacterium
tuberculosis DNA and immunohistochemical analysis for
B124 antibody raised against Mycobacterium bovis were nega-
tive. Shortly after, the patient developed multiple cutaneous
papules located on the head and neck region measuring ap-
proximately 3 to 4 mm in diameter (Fig. 1). The papules did not
coalesce and did not show spontaneous regression. Histopath-
ologic examination of one papule located on the temporal re-
gion demonstrated a dense atypical lymphoid infiltrate com-
posed predominantly of large pleomorphic lymphocytes with
rare, small, round lymphocytes within the superficial and
middle dermis (Fig. 2A). The large hyperchromatic cells
showed an irregular nuclear contour and irregular chromatin
distribution. Some of the cells had prominent large nucleoli
(Fig. 2B). Numerous mitotic figures were observed. Immuno-
histochemical analysis demonstrated diffuse CD3 expression.
CD30 was expressed in approximately 30% of the infiltrate
and in almost all large lymphocytes (Fig. 2C). Numerous
CD68+ histiocytes were present, although well organized
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granulomas were not detected. The B-cell marker CD20
stained less than 5% of the cells. The proliferation marker
Mib-1 was expressed in approximately 80% of lymphoid cells.
T-cell receptor rearrangement was negative. A second skin bi-
opsy was performed on another papule. Histopathologically, a
non-necrotizing granulomatous dermatitis with variable num-
bers of giant cells was observed. A CD30 stain was negative.
The immunologic profile on peripheral blood revealed that the
percentage of CD4+/CD30+ was only 0.2%. A Mantoux test,
with the intradermal injection of 5 TU PPD-S, showed an in-
duration of 30 mm after 48 to 72 hours, strongly supporting a
diagnosis of TBC. Polymerase chain reaction identification of
Mycobacterium tuberculosis, performed on microbiologic cul-
tures of a cutaneous sample, was negative. Upon diagnosis, the
patient was given antitubercular therapy consisting of rifampi-
cin (600 mg qd), isoniazid (300 mg qd), ethambutol (500 mg
bid), and pyrazinamide (500 mg bid) daily for 2 months, fol-
lowed by 2 drugs (rifampicin and isoniazid) for 6 months. The
therapy led to a significant reduction of lymph node swellings,
whereas the cutaneous lesions ran a more prolonged course
and cleared completely after 12 months. Neither complications
nor drug-dependent side effects occurred.
DISCUSSION
Although available histopathologic and molecular data
do not allow to definitively establish that in the current case the
lymph node and skin lesions were due to TBC infection, the
results of the Mantoux reaction and of the second skin biopsy,
along with the resolution of the lymph node and cutaneous le-
sions upon antitubercular therapy, were highly suggestive for
TBC. Indeed, it is known that suboptimal fixation combined
with a very low amount of mycobacteria in the tissue sample
may lead to a false negative result of the polymerase chain
reaction from formalin-fixed, paraffin-embedded tissue. The
open issue is why apparently similar cutaneous lesions showed
different histopathologic features. In particular, it is debatable
whether the peculiar picture observed in the first skin biopsy
may, in this clinical setting, be classified as a form of tubercu-
lid, since this concept has been challenged from time to time
FIGURE 1. Multiple cutaneous papules measuring approxi-
mately 3 to 4 mm in diameter located on the head region.
FIGURE 2. (A) Histopathologic examination showed a dense
atypical lymphoid infiltrate composed predominantly of large
pleomorphic lymphocytes with rare smaller lymphocytes
within the superficial and middle dermis. (B) The atypical pleo-
morphic cells showed an irregular nuclear contour, irregular
chromatin distribution, and prominent large nucleoli. (C)
CD30 strong immunoreactivity was observed in the large pleo-
morphic lymphocytes.
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and since it is not yet clear which clinicopathologic entities can
be classified under this term. On clinical grounds, the papular
eruption was reminiscent of so-called “lupus miliaris dissemi-
natus faciei,” originally thought to be a variant of lupus vul-
garis or a tuberculid due to its histopathologic similarity with
TBC. However, the terminology, pathogenesis, and the asso-
ciation of lupus miliaris disseminatus faciei with TBC have
been recently questioned.1
In the current case, we were concerned by the presence
in the first skin biopsy of large, atypical CD30+ pleomorphic
lymphocytes within the dermis. Although a CD30+ cutaneous
lymphoproliferative lesion, in particular, lymphomatoid papu-
losis, was initially considered, clinical features (absence of ne-
crosis and ulceration, crusting, and spontaneous regression)
and laboratory findings supported the reactive nature of the
infiltrate. Conversely, the absence of T-cell receptor gene re-
arrangement did not per se rule out lymphomatoid papulosis.
On histopathologic examination, the differential diagno-
sis of an atypical CD30+ lymphoid proliferation is broad and
includes primary cutaneous CD30+ T-cell lymphoprolifera-
tive disorders (including lymphomatoid papulosis, primary cu-
taneous anaplastic large cell lymphoma, and borderline le-
sions) and reactive infiltrates in response to pharmaceutical
agents (such as carbamazepine) or viral infections (especially
herpes virus, human papillomavirus, and Epstein-Barr virus
infections).2,3 As rule, only a minority of the infiltrate in non-
neoplastic conditions is CD30+, and rarely is there clustering
of the CD30+ lymphoid population. Among inflammatory
conditions of the skin, atypical CD30+ lymphocytes have been
described in rare cases of atopic dermatitis,4 molluscum con-
tagiosum,5 and recently, in association with a delayed skin re-
action to coelenterates.6
CD30 is a member of the tumor necrosis/nerve growth
factor receptor superfamily, originally described as a marker
for Hodgkin and Reed-Sternberg cells in Hodgkin disease, but
subsequently found on various non-Hodgkin lymphomas and
on activated T and B cells.7,8 Moreover, CD30 is consistently
expressed by human CD4+ TH2 and TH0 and CD8
+ type 2 cy-
totoxic T-cell clones, whereas CD4+ TH1 and CD8
+ type 1 cy-
totoxic clones usually exhibit poor or no CD30 expression.9
Therefore, the CD30 molecule is generally regarded as a puta-
tive specific marker of inflammatory infiltrates with a TH2-
type cytokine pattern.
In the pathogenesis of human TBC, whether strict TH1-
like (type 1) or TH2-like (type 2) cytokine profiles occur is still
a controversial issue. The dominant view has been that there is
little or no activation of TH2-like cytokine production in hu-
man TBC. However, a series of publications have demon-
strated that there might be an inappropriate TH2-like compo-
nent in many affected patients.10–12 It has also been suggested
that cytokine profiles in mycobacterial diseases may vary ac-
cording to different anatomic sites and depending on the se-
verity of the disease.13 In line with our observations, increased
CD30 expression by Mycobacterium tuberculosis–stimulated
/ and / T cells and elevated numbers of CD30+ / T
cells have been demonstrated in TBC pleuritis and affected
lung tissue.14 Taken together, these results indicate that Myco-
bacterium tuberculosis is a potent inducer of CD30 expression
in TH1-like cells and argue against the exclusive correlation of
CD30 expression with TH2-like cell responses.
In conclusion, the present case enlarges the spectrum of
inflammatory infiltrates in which atypical CD30+ cells may be
found. Since the reactive atypical CD30+ cells are morpho-
logically similar to those cells observed in CD30+ lymphopro-
liferative disorders, including lymphomatoid papulosis, com-
plete clinical history and laboratory findings are necessary to
make the final and correct diagnosis. Although the pathoge-
netic relevance of the presence of CD30+ cells within the cu-
taneous infiltrate of patients with systemic TBC remains to be
determined, our findings support the hypothesis that the TBC-
associated cytokines’ profile might not be strictly TH1-like,
but a TH1-like to TH2-like switching may also occur.
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